Search results
Showing 91 to 105 of 118 results for osteoarthritis
We have moved interventional procedures guidance 538 to become HealthTech guidance 393. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Platelet-rich plasma injections for knee osteoarthritis (IPG637)
We have moved interventional procedures guidance 637 to become HealthTech guidance 497. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved interventional procedures guidance 702 to become HealthTech guidance 588. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Platelet-rich plasma injections for osteoarthritis of the knee (IPG491)
This guidance has been updated and replaced by NICE interventional procedures guidance 637.
NICE has developed a medtech innovation briefing (MIB) on The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs .
NICE has developed a medtech innovation briefing (MIB) on Mobi-C for cervical disc replacement
Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis (IPG111)
We have moved interventional procedures guidance 111 to become HealthTech guidance 67. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Genicular artery embolisation for pain from knee osteoarthritis (IPG708)
We have moved interventional procedures guidance 708 to become HealthTech guidance 595. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis (IPG726)
We have moved interventional procedures guidance 726 to become HealthTech guidance 626. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Joint distraction for knee osteoarthritis without alignment correction (IPG529)
We have moved interventional procedures guidance 529 to become HealthTech guidance 381. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Cox-II inhibitors for the treatment of osteoarthritis and rheumatoid arthritis (TA27)
This guidance has been replaced by NICE guideline CG59 and NICE guideline CG79.
Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis (IPG230)
Interventional procedures, IPG230 - Issued: August 2007 --> We have moved interventional procedures guidance 230 to become HealthTech guidance 148. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
The Juxta CURES adjustable compression system for treating venous leg ulcers (MIB25)
NICE has developed a medtech innovation briefing (MIB) on the Juxta CURES adjustable compression system for treating venous leg ulcers
This guideline covers interventions to maintain and improve the mental wellbeing and independence of people aged 65 or older and how to identify those most at risk of a decline.
We have moved interventional procedures guidance 727 to become HealthTech guidance 627. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.